Saltar al contenido
Dispositivos y mediciónArtículo de investigación3 min read

Smartwatch multi-lead ECG matched a standard 12-lead ECG for ST-segment changes in 100 people

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes. · JAMA cardiology · 2020 · Artículo original ↗

Idea principal

In 100 participants, a commercial smartwatch placed at different body positions agreed closely with a standard 12-lead ECG, with Cohen kappa 0.88 for ST elevation and 0.85 for non-ST elevation changes; sensitivity was 93% and 94% and specificity 95% and 92%. Only 81 people had a heart attack and 19 were healthy, and recordings were taken under supervised conditions, so this is not a test for use at home.

Study design

Artículo de investigación

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Acute coronary syndromes, such as heart attacks, are a leading cause of death, and quick diagnosis from an ECG is essential. The authors tested whether a smartwatch, normally a single-lead device, could record multiple ECG leads from different body positions and detect the ST-segment changes seen in heart attacks.

Población y método

Prospective study from April 19, 2019 to January 23, 2020 in 100 participants: 54 with ST elevation myocardial infarction, 27 with non-ST elevation myocardial infarction and 19 healthy individuals. The watch was placed in different body positions to record 9 bipolar ECG tracings (matching Einthoven leads I, II and III and precordial leads V1-V6), compared with a simultaneous standard 12-lead ECG. Agreement was assessed with the Cohen kappa coefficient and Bland-Altman analysis. 67 participants were men (67%); mean age was 61 years (SD 16).

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Agreement between smartwatch and standard ECG was high for a normal ECG (kappa 0.90, 95% CI 0.78-1.00), ST-segment elevation (kappa 0.88, 95% CI 0.78-0.97) and non-ST-segment elevation changes (kappa 0.85, 95% CI 0.74-0.96).
  2. 2
    For the amplitude of ST-segment changes, Bland-Altman analysis showed agreement (bias -0.003, SD 0.18, lower limit -0.36, upper limit 0.36).
  3. 3
    For ST elevation, sensitivity was 93% (95% CI 82%-99%) and specificity 95% (95% CI 85%-99%); for non-ST elevation ECG alterations, sensitivity was 94% (95% CI 81%-99%) and specificity 92% (95% CI 83%-97%).
  4. 4
    For identifying a normal ECG, sensitivity was 84% (95% CI 60%-97%) and specificity 100% (95% CI 95%-100%).

Límites e incertidumbre

  1. 1
    Only 19 healthy people and 100 participants overall, so the confidence intervals for some measures, such as 84% sensitivity for a normal ECG (60%-97%), are wide.
  2. 2
    Participants were already known heart attack patients or healthy volunteers, so this does not show how well a watch would find ST changes in people with unclear symptoms.
  3. 3
    The watch was repositioned to build 9 tracings in a controlled setting, which is not what happens when someone presses a watch during chest pain at home.
  4. 4
    This reading is based on the abstract only.

Relevancia práctica

The study suggests a smartwatch can in principle record a multi-lead ECG close to a standard one, which could one day help with remote assessment of chest pain. It does not mean a watch can detect a heart attack on its own. Chest pain, pressure or other emergency symptoms call for emergency care, not a watch reading.

Tus datos

A single-lead ECG feature on a consumer watch cannot replace what was done here, which required placing the watch at nine body positions. Use ECG or heart-rhythm features for what they are approved for, and treat any reading as something to discuss with a clinician, not as a way to rule out a heart attack.

Cómo interpretar la evidencia

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Importance

Acute coronary syndromes are the leading cause of death worldwide and the leading cause of disease burden in high-income countries. Quick and accurate diagnosis of acute coronary syndromes is essential to avoid fatal events, for timely intervention, and to improve the prognosis.

Objective

To prospectively investigate the feasibility and accuracy of a smartwatch in recording multiple electrocardiographic (ECG) leads and detecting ST-segment changes associated with acute coronary syndromes compared with a standard 12-lead ECG.

Design, setting, and participants

A commercially available smartwatch was used in 100 participants to obtain multiple-channel ECGs. The study was conducted from April 19, 2019, to January 23, 2020. Fifty-four patients with ST elevation myocardial infarction, 27 patients with non-ST elevation myocardial infarction, and 19 healthy individuals were included in the study. The watch was placed in different body positions to obtain 9 bipolar ECG tracings (corresponding to Einthoven leads I, II, and III and precordial leads V1-V6) that were compared with a simultaneous standard 12-lead ECG.

Main outcomes and measures

The concordance among the results of the smartwatch and standard ECG recordings was assessed using the Cohen κ coefficient and Bland-Altman analysis.

Results

Of the 100 participants in the study, 67 were men (67%); mean (SD) age was 61 (16) years. Agreement was found between the smartwatch and standard ECG for the identification of a normal ECG (Cohen κ coefficient, 0.90; 95% CI, 0.78-1.00), ST-segment elevation changes (Cohen κ coefficient, 0.88; 95% CI, 0.78-0.97), and non-ST-segment elevation changes (Cohen κ coefficient, 0.85; 95% CI, 0.74-0.96). In addition, the Bland-Altman analysis demonstrated agreement between the smartwatch and standard ECG to detect the amplitude of ST-segment changes (bias, -0.003; SD, 0.18; lower limit, -0.36; and upper limit, 0.36). Use of the smartwatch ECG for the diagnosis of normal ECG showed a sensitivity of 84% (95% CI, 60%-97%) and specificity of 100% (95% CI, 95%-100%); for ST elevation, sensitivity was 93% (95% CI, 82%-99%) and specificity was 95% (95% CI, 85%-99%); and for NSTE ECG alterations, sensitivity was 94% (95% CI, 81%-99%) and specificity was 92% (95% CI, 83%-97%).

Conclusions and relevance

The findings of this study suggest agreement between the multichannel smartwatch ECG and standard ECG for the identification of ST-segment changes in patients with acute coronary syndromes.

Fuentes y atribución

Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes.

Spaccarotella CAM, Polimeni A, Migliarino S, Principe E, Curcio A, Mongiardo A, Sorrentino S, De Rosa S, Indolfi C.

JAMA cardiology · 2020-10-01

DOI: 10.1001/jamacardio.2020.3994 ↗PubMed · 32865545 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Estudio de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explicaciones detalladasLeer estudio →
·Revisión de revisiones

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explicaciones detalladasLeer estudio →
Dispositivos y medición →